4:01 PM ET
8-K/A
M&A Deal
Tarsus Pharmaceuticals M&A Deal with Alkeus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals filed an amendment to its previous 8-K to provide required historical and pro forma financial statements following its acquisition of Alkeus Pharmaceuticals. The acquisition was originally completed on September 4, 2026, pursuant to a merger agreement dated July 31, 2026.
- Counterparty
- Alkeus Pharmaceuticals, Inc.